| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1419 | 2020 |
| SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 J Braun, L Loyal, M Frentsch, D Wendisch, P Georg, F Kurth, ... Nature 587 (7833), 270-274, 2020 | 1314 | 2020 |
| COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis RL Chua, S Lukassen, S Trump, BP Hennig, D Wendisch, F Pott, ... Nature biotechnology 38 (8), 970-979, 2020 | 1110 | 2020 |
| Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection CB Messner, V Demichev, D Wendisch, L Michalick, M White, A Freiwald, ... Cell systems 11 (1), 11-24. e4, 2020 | 526 | 2020 |
| SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis D Wendisch, O Dietrich, T Mari, S von Stillfried, IL Ibarra, M Mittermaier, ... Cell 184 (26), 6243-6261. e27, 2021 | 405 | 2021 |
| Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study D Hillus, T Schwarz, P Tober-Lau, K Vanshylla, H Hastor, C Thibeault, ... The Lancet Respiratory Medicine 9 (11), 1255-1265, 2021 | 373 | 2021 |
| A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model J Kreye, SM Reincke, HC Kornau, E Sánchez-Sendin, VM Corman, H Liu, ... Cell 183 (4), 1058-1069. e19, 2020 | 354 | 2020 |
| A time-resolved proteomic and prognostic map of COVID-19 V Demichev, P Tober-Lau, O Lemke, T Nazarenko, C Thibeault, ... Cell systems 12 (8), 780-794. e7, 2021 | 168 | 2021 |
| Monkeypox in-patients with severe anal pain F Pfäfflin, D Wendisch, R Scherer, L Jürgens, G Godzick-Njomgang, ... Infection 51 (2), 483-487, 2023 | 63 | 2023 |
| Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19 M Aznaourova, N Schmerer, H Janga, Z Zhang, K Pauck, J Bushe, ... Proceedings of the National Academy of Sciences 119 (36), e2120680119, 2022 | 33 | 2022 |
| Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study B Mühlemann, C Thibeault, D Hillus, ET Helbig, LJ Lippert, P Tober-Lau, ... Clinical Microbiology and Infection 27 (10), 1520. e7-1520. e10, 2021 | 19 | 2021 |
| Human recombinant monoclonal antibody against sars-cov-2 spike glycoprotein J Kreye, H Pruss, SM Reincke, HC Kornau, E Sanchez-sendin, ... US Patent App. 17/928,013, 2024 | | 2024 |
| Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses J Lesbats, A Brillac, J Haines, P Mukherjee, M Fernández-Monreal, ... | | 2024 |
| Macrophage and Monocyte Responses to SARS-CoV-2 DC Wendisch | | 2024 |
Leif Erik Sander, MDDepartment of Infectious Diseases & Respiratory Medicine Charité - Universitätsmedizin BerlinEmail yang diverifikasi di charite.de